April 10, 2012

Ethics Grand Rounds on prenatal testing for Down syndrome Friday, April 13

It is now possible to receive a non-invasive prenatal test for Down syndrome that can be administered at 10 weeks of gestation and reportedly has 99 percent accuracy.

As technology advances and allows for genetic tests such as MaterniT21 to be developed, what ethical considerations arise? The Vanderbilt Kennedy Center will host "Crossroads of Technology and Ethics: Implications of Prenatal Testing for Down Syndrome," Friday, April 13, at noon in One Magnolia Circle, Kennedy Center room 241.

Panelists include Robert Hodapp, Ph.D., professor of Special Education and director of Research, Vanderbilt Kennedy Center UCEDD; Frank Boehm, M.D., professor of Obstetrics and Gynecology and associate professor of Radiology and Radiological Sciences; Martha Dudek, M.S., LCGC, genetic counselor, senior associate in Obstetrics and Gynecology and associate in Pediatrics; and Christine Sartain, parent advocate.